|
|
.
See Category: Injury, poisoning and certain other consequences of external causes
See Header: Toxic effect of lead and its compounds, undetermined
ICD-10 (CM) Code and Descriptor
|
T56.0X4S |
Toxic effect of lead and its compounds, undetermined, sequela
|
T560X4S utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 11.29%
|
20.97%
|
12.90%
|
8.06%
|
8.06%
|
11.29%
|
14.52%
|
4.84%
|
4.84%
|
3.23%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for T56.0X4S*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
83655
|
ASSAY OF LEAD |
16
|
16
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
9
|
9
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
6
|
6
|
|
80053
|
COMPREHEN METABOLIC PANEL |
6
|
6
|
|
80048
|
METABOLIC PANEL TOTAL CA |
5
|
5
|
|
80061
|
LIPID PANEL |
3
|
3
|
|
G0103
|
PSA SCREENING |
2
|
2
|
|
84439
|
ASSAY OF FREE THYROXINE |
2
|
2
|
|
84443
|
ASSAY THYROID STIM HORMONE |
2
|
2
|
|
83036
|
HEMOGLOBIN GLYCOSYLATED A1C |
2
|
2
|
|
83519
|
RIA NONANTIBODY |
1
|
1
|
|
83921
|
ORGANIC ACID SINGLE QUANT |
1
|
1
|
|
99214
|
OFFICE O/P EST MOD 30 MIN |
1
|
1
|
|
36589
|
REMOVAL TUNNELED CV CATH |
1
|
1
|
|
81378
|
HLA I & II TYPING HR |
1
|
1
|
|
86828
|
HLA CLASS I&II ANTIBODY QUAL |
1
|
1
|
|
86832
|
HLA CLASS I HIGH DEFIN QUAL |
1
|
1
|
|
86833
|
HLA CLASS II HIGH DEFIN QUAL |
1
|
1
|
|
86849
|
IMMUNOLOGY PROCEDURE |
1
|
1
|
|
80305
|
DRUG TEST PRSMV DIR OPT OBS |
1
|
1
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
T56.0X4S related to the following DRG Codes:
922-923
|
